Psychiatric Times Editors

In honor of Independence Day, Psychiatric Times™ contributors weigh in.

The experts weighed in on a wide variety of psychiatric issues for the June 2022 issue of Psychiatric Times.

Over the past 6 months, Psychiatric Times has featured expert opinions on important psychiatric issues from psychosis to psychedelics.

Catch up on the latest research on ADHD, PTSD, and more with Psychiatric Times.

In honor of Juneteenth, Psychiatric Times™ highlights the significant contributions of Black individuals to the field of psychiatry and issues impacting both patients and clinicians in this underrepresented community.

What are your thoughts on psychedelics?

A look at the theme for the 2022 American Psychiatric Association Annual Meeting.

Are you attending APA’s 2022 Annual Meeting in New Orleans? Don’t miss us!

MAD Arts features works by artists recovering from mental illness in special exhibition in partnership with National Art Exhibitions of the Mentally Ill.

The first week of May is National Correctional Officers and Employees Week.

The experts weighed in on a wide variety of psychiatric issues for the April 2022 issue of Psychiatric Times.

Psychiatric Times contributors share poems about psychiatric issues from grief to Black mental health.

Tell us about your hobbies and activities for a chance to be featured in our video series, After Hours.

The new 988 National Suicide Prevention Lifeline hopes to save lives, and we want to know your thoughts on it.

Mental health and medical care are the focus of the upcoming NCCHC in-person and virtual conferences on correctional health care.

Can you spare a minute to share your insights?

Are you interested in sharing your story?

What are your thoughts on medical aid in dying?

Is ECT a viable or a dangerous treatment for psychiatric disorders? Is there a middle road? Share your thoughts in our poll.

Research on psychiatrists' attitudes on the potential of cannabis in psychiatry.

Enlightening survey results reveal what psychiatrists think about medical marijuana/cannabis use, how or whether to discuss with their patients, and what biases might get in the way of such conversations.

How often do your patients share with you the positive and negative effects of medications?

Join the conversation on Psychiatric Times

What are your thought about navigating these uncharted waters?

When hoarding disorder is suspected, it is important to assess for other psychiatric disorders that may affect the presentation and treatment of symptoms. Find out more in this quiz.

What are your thoughts about prescribing medical marijuana/cannabis to treat psychiatric disorders?

What are your feelings about the utility of cannabis in psychiatric practice?

As our knowledge about herbal cannabis, the endocannabinoid system, and cannabinoid pharmacology expands, should psychiatrists discuss these issues with their patients?